PAREXEL RECIST 1.1!

Learn about RECIST 1.1 and how it can be applied to your clinical trial. RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve (respond), stay the same (stable) or worsen (progression) during treatments.